New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by multi-drug-resistant Gram-positive pathogens. Each of these agents contains a heptapeptide core, common to all glycopeptides, which enables them to inhibit transglycosylation and transpeptidati...
Alternative Titles
Full title
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_744699878
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_744699878
Other Identifiers
ISSN
0012-6667
E-ISSN
1179-1950
DOI
10.2165/11534440-000000000-00000
